Form 4: Flex COO Files Plan to Sell 12,500 Shares Under 10b5-1 Plan

Flex Ltd.'s Chief Operating Officer, Tan Kwang Hooi, has filed a Form 4 indicating a future sale of 12,500 ordinary shares on July 28, 2025, under a Rule 10b5-1 trading plan.

Summary

• Chief Operating Officer Tan Kwang Hooi of Flex Ltd. reported a planned sale of 12,500 ordinary shares.
• The transaction is scheduled for July 28, 2025.
• The sale was effected pursuant to a Rule 10b5-1 trading plan.
• The weighted average sales price for the transaction is $50.2482, with actual sales prices ranging from $49.92 to $50.68.
• Following this planned transaction, Tan Kwang Hooi will beneficially own 263,636 ordinary shares.
• Current beneficial ownership includes 23,981 unvested restricted share units (RSUs) vesting in two equal annual installments starting June 12, 2026.
• Also included are 21,964 unvested RSUs vesting in three equal annual installments starting June 12, 2026.
• An additional 16,195 unvested RSUs are set to vest on June 14, 2026.
• Finally, 72,578 unvested RSUs will vest on September 25, 2027.

Sentiment

Score: 5

Explanation: A neutral score. Insider sales, especially under a 10b5-1 plan, are often routine and not necessarily indicative of negative sentiment towards the company. It's a personal financial management decision.

Positives

• The sale is conducted under a Rule 10b5-1 trading plan, which indicates a pre-arranged sale designed to avoid accusations of insider trading and provides transparency.

Negatives

• An insider selling shares, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake, though this is a routine personal financial management action.

Future Outlook

The filing indicates a pre-scheduled sale of shares by a key executive in the future, specifically on July 28, 2025, as part of a Rule 10b5-1 trading plan. It also details future vesting schedules for a significant number of restricted share units held by the executive, extending through September 2027.

Management Comments

• The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction. Such filings are common across all industries as executives manage their personal portfolios and compensation. The use of a Rule 10b5-1 plan is a standard practice for corporate insiders to sell shares without being accused of trading on material non-public information.

Comparison to Industry Standards

• Insider sales under Rule 10b5-1 plans are a common and accepted practice for executives across various industries, including technology and manufacturing, to manage their equity compensation and personal finances while adhering to insider trading regulations.
• There are no specific comparable companies or projects mentioned in this filing to provide a direct comparison of the transaction itself, as it pertains to an individual's personal stock management.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in the COO's direct equity stake, but the use of a 10b5-1 plan mitigates concerns about opportunistic selling.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• The planned sale of 12,500 ordinary shares is scheduled for July 28, 2025.
• Various tranches of unvested restricted share units (RSUs) held by the COO are scheduled to vest on June 12, 2026, June 14, 2026, and September 25, 2027.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled insider sale under a Rule 10b5-1 plan by the Chief Operating Officer. Such transactions are typically for personal financial planning and do not inherently signal a change in the company's fundamental outlook or performance. The amount sold is relatively small compared to the executive's total beneficial ownership, which still includes a significant number of unvested RSUs. Therefore, the filing itself does not provide a strong basis for a 'buy' or 'sell' recommendation, suggesting a 'hold' position as the market impact is likely minimal.

Keywords

Flex Ltd., FLEX, Form 4, Insider Trading, Beneficial Ownership, Rule 10b5-1, Share Sale, Executive Compensation, Restricted Share Units, Tan Kwang Hooi